BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6087717)

  • 1. Anaerobic infection in the neutropenic host: anti-endotoxin effect of polymyxin.
    Bannatyne RM; Cheung R
    Anticancer Res; 1984; 4(3):169-70. PubMed ID: 6087717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infection in neutropenia: Anti-endotoxin effect of polymyxin.
    Bannatyne RM; Cheung R
    Anticancer Res; 1982; 2(4):239-40. PubMed ID: 6293368
    [No Abstract]   [Full Text] [Related]  

  • 3. Integrated management of bacteraemic shock in neutropenia.
    Bannatyne RM; Cheung R
    Anticancer Res; 1983; 3(4):233-4. PubMed ID: 6309069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anaerobic sepsis].
    Russu VG
    Klin Med (Mosk); 1983 Nov; 61(11):11-7. PubMed ID: 6141318
    [No Abstract]   [Full Text] [Related]  

  • 5. Protective effect of polymyxin B sulfate in experimental meningococcal infection in mice.
    Bannatyne RM; Harnett NM; Cheung R
    Can J Microbiol; 1977 Nov; 23(11):1526-8. PubMed ID: 200329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metronidazole hydrochloride (Flagyl I.V.).
    Med Lett Drugs Ther; 1981 Feb; 23(4):13-4. PubMed ID: 7464682
    [No Abstract]   [Full Text] [Related]  

  • 7. [Increase of anaerobic infections. Prevalence of Bacteroides. Apropos of 17 cases in abdominal surgery].
    Coulbois B; Legall N; Blondel P; Riche D; Curtet N; Guesnon P; Guéry J
    Anesth Analg (Paris); 1977; 34(2):367-79. PubMed ID: 900536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of antimicrobial combinations in the therapy of infections in neutropenic patients.
    Gialdroni Grassi G; Grassi C
    Chemioterapia; 1987 Jun; 6(2 Suppl):398-400. PubMed ID: 3334582
    [No Abstract]   [Full Text] [Related]  

  • 9. [Bacterial septicemia in neutropenia patients].
    Vernant JP; Thibault M; Cordonnier C; Feghali W; Brun B; Dreyfus B; Duval J; Rochant H
    Ann Med Interne (Paris); 1983; 134(7):629-35. PubMed ID: 6666900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention of bacterial and fungal infections in neutropenic patients with malignant hematologic diseases].
    Candoni A; Russo D; Salmaso F
    Clin Ter; 1997; 148(1-2):23-8. PubMed ID: 9377834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endotoxins of anaerobic gram-negative rods.
    Hofstad T; Sveen K
    Scand J Infect Dis Suppl; 1979; (19):42-5. PubMed ID: 88759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of polymyxin B sulfate in experimental enterobacterial infection in mice.
    Bannatyne RM; Cheung R
    Can J Microbiol; 1979 Sep; 25(9):995-8. PubMed ID: 232006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Office treatment of anaerobic infections.
    Bartlett JG
    Med Times; 1977 Sep; 105(9):16d (130)-8d (130). PubMed ID: 561288
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunoprophylaxis of gram-negative infections: background for a prophylactic study of purified anticore-glycolipid immunoglobulins in neutropenic patients.
    Glauser MP
    Schweiz Med Wochenschr Suppl; 1983; 14():35-9. PubMed ID: 6361989
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diagnosis and treatment of infection in the support of the neutropenic patient].
    Rafecas FJ; Sanz MA; Martín-Aragones G; Martínez JA; Sayas MJ; Marty ML
    Sangre (Barc); 1985; 30(4-B):501-14. PubMed ID: 4081964
    [No Abstract]   [Full Text] [Related]  

  • 16. Evidence for antibiotic-mediated endotoxin release as a contributing factor to lethality in experimental gram-negative sepsis.
    Morrison DC; Bucklin SE
    Scand J Infect Dis Suppl; 1996; 101():3-8. PubMed ID: 9060044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of chemoprophylaxis and therapy of bacterial infections in neutropenic patients.
    Klastersky J
    Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):201S-207S. PubMed ID: 2686921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic choice in the neutropenic patient.
    Winslow DL
    Del Med J; 1984 Jul; 56(7):413-5. PubMed ID: 6479386
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of moxifloxacin versus imipenem/cilastatin treatment on the mortality of mice infected intravenously with different strains of Bacteroides fragilis and Escherichia coli.
    Schaumann R; Blatz R; Beer J; Ackermann G; Rodloff AC
    J Antimicrob Chemother; 2004 Feb; 53(2):318-24. PubMed ID: 14729746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The treatment of serious anaerobic infections.
    Greenberg RN; Scalcini MC; Sanders CV; Lewis AC
    Scand J Infect Dis Suppl; 1980; suppl 25():84-8. PubMed ID: 7010541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.